CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION
Lynch, J., Chun, DS., Berse, B., Venne, V., Efimova, O., DuVall, S., Filipski, KK., & Kelley, MJ. (2016). CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION. Value in Health, 19(3), A312-A312. https://doi.org/10.1016/j.jval.2016.03.2017
Abstract
Appropriate use of of the 21-gene RS test decreased use of chemotherapy among low risk patients, and produced significant cost savings and potential improvements in health outcomes. Our study demonstrated opportunities to improve access to testing for eligible Veterans.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.